475 filings
Page 4 of 24
8-K
v9u2 ivv6zq71dp
11 Aug 22
NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022
8:05am
DEFA14A
m3xslewgovmo91 hrhqj
22 Jul 22
Additional proxy soliciting materials
4:36pm
8-K
2uqfnowncbo
29 Jun 22
NeuBase Therapeutics Announces Promotion of Dr. William Mann to President and COO
8:03am
8-K
kuzt207j91rso
12 May 22
NeuBase Therapeutics Reports Business Update and Financial Results
5:01pm
S-8
1no8v3sq 1tdi
8 Apr 22
Registration of securities for employees
4:53pm
8-K
vvilvc1w8m0u7dh72
14 Mar 22
Regulation FD Disclosure
6:07am
8-K
r45o 5l5io2j
11 Feb 22
NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2022
12:00am
8-K
w3afpz
10 Jan 22
NeuBase Therapeutics Appoints Todd P. Branning Chief Financial Officer
4:06pm
8-K
qiy1oi6lag
5 Jan 22
NeuBase Therapeutics Appoints Dr. Eric J. Ende to Board of Directors
4:03pm
8-K
fsxofnrmni
23 Dec 21
NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021
4:02pm
8-K
x7wevnhw pb
22 Oct 21
Departure of Directors or Certain Officers
4:17pm
8-K
oj2duo4bk8a
1 Oct 21
Departure of Directors or Certain Officers
4:17pm
424B5
jtdkb352rdfcnfqebes
27 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
klyqlxivz8
27 Aug 21
Entry into a Material Definitive Agreement
12:00am